4//SEC Filing
THOMAS TOM C 4
Accession 0000950170-24-097330
CIK 0001796129other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:11 PM ET
Size
33.6 KB
Accession
0000950170-24-097330
Insider Transaction Report
Form 4
THOMAS TOM C
See Remarks
Transactions
- Award
Stock Option (right to buy)
2024-08-12+55,250→ 55,250 totalExercise: $0.55Exp: 2032-02-13→ Common Stock (55,250 underlying) - Award
Stock Option (right to buy)
2024-08-12+58,000→ 58,000 totalExercise: $0.55Exp: 2032-08-24→ Common Stock (58,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−93,750→ 0 totalExercise: $7.38Exp: 2034-03-06→ Common Stock (93,750 underlying) - Award
Stock Option (right to buy)
2024-08-12+93,750→ 93,750 totalExercise: $0.55Exp: 2034-03-06→ Common Stock (93,750 underlying) - Award
Stock Option (right to buy)
2024-08-12+175,000→ 175,000 totalExercise: $0.55Exp: 2031-03-14→ Common Stock (175,000 underlying) - Award
Stock Option (right to buy)
2024-08-12+86,000→ 86,000 totalExercise: $0.55Exp: 2033-02-14→ Common Stock (86,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−31,250→ 0 totalExercise: $7.38Exp: 2034-03-06→ Common Stock (31,250 underlying) - Award
Stock Option (right to buy)
2024-08-12+31,250→ 125,000 totalExercise: $0.55Exp: 2034-03-06→ Common Stock (31,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−56,000→ 0 totalExercise: $0.82Exp: 2032-11-14→ Common Stock (56,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−86,000→ 0 totalExercise: $1.17Exp: 2033-02-14→ Common Stock (86,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−175,000→ 0 totalExercise: $23.75Exp: 2031-03-14→ Common Stock (175,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−55,250→ 0 totalExercise: $6.26Exp: 2032-02-13→ Common Stock (55,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-08-12−58,000→ 0 totalExercise: $1.71Exp: 2032-08-24→ Common Stock (58,000 underlying) - Award
Stock Option (right to buy)
2024-08-12+56,000→ 56,000 totalExercise: $0.55Exp: 2032-11-14→ Common Stock (56,000 underlying)
Footnotes (7)
- [F1]On August 12, 2024, the stockholders of the Issuer approved the repricing of certain outstanding options to purchase common stock (the "Repriced Options"), with the new exercise price being the closing price of the Issuer's common stock on the Nasdaq Capital Market on August 12, 2024, rounded up to the nearest penny (the "Repricing"). There is no change to the number of shares underlying the Repriced Options or the vesting schedule or expiration dates of the Repriced Options. The Repricing was approved by the Board of Directors of the Issuer on June 26, 2024, based on the recommendation of the Compensation Committee of the Board of Directors.
- [F2]Option vests over three years, with 1/3 of the shares vesting on March 15, 2022, and 1/36th of the shares vesting monthly thereafter.
- [F3]Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.
- [F4]Option vests in twenty-four equal monthly installments starting from August 25, 2022.
- [F5]Option vests in twenty-four equal monthly installments starting from November 15, 2022.
- [F6]Option vests in twenty-four equal monthly installments starting from February 15, 2023.
- [F7]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001239202
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:11 PM ET
- Size
- 33.6 KB